Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
NORGESTREL (UNII: 3J8Q1747Z2) (NORGESTREL - UNII:3J8Q1747Z2), ETHINYL ESTRADIOL (UNII: 423D2T571U) (ESTRADIOL - UNII:4TI98Z838E)
Physicians Total Care, Inc.
NORGESTREL
NORGESTREL 0.3 mg
ORAL
PRESCRIPTION DRUG
Low-Ogestrel® (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception.1 The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. Oral contraceptives should not be used in women who have the following conditions: - Thrombophlebitis or thromboembolic disorders Thrombophlebitis or thromboembolic disorders - A past history of deep vein thrombophlebitis or thromboembolic disorders A past history of deep vein thrombophlebitis or thromboembolic disorders - Cerebral vascular or coronary artery disease Cerebral vascular or coronary artery disease - Known or suspected carcinoma of the
Low-Ogestrel® Tablets (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) NDC 54868-4850-0 : Each white tablet is unscored, round in shape, with 847 debossed on one side and WATSON on the other side, and contains 0.3 mg norgestrel and 0.03 mg ethinyl estradiol. Low-Ogestrel® is packaged in cartons of dispensers. Each tablet dispenser contains 21 white (active) tablets and 7 peach (inert) tablets. Inert tablets are unscored, round in shape with WATSON debossed on one side and P1 on the other side. STORAGE: Store at controlled room temperature 15°C to 25°C (59°F to 77°F). Keep this and all medications out of the reach of children.
Abbreviated New Drug Application
LOW-OGESTREL - NORGESTREL AND ETHINYL ESTRADIOL PHYSICIANS TOTAL CARE, INC. ---------- PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. ORAL CONTRACEPTIVE AGENTS DESCRIPTION _LOW-OGESTREL _ Tablets (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) provide an oral contraceptive regimen consisting of 21 white tablets followed by 7 peach tablets. Each white tablet, for oral administration contains 0.3 mg of norgestrel and 0.03 mg ethinyl estradiol and the following inactive ingredients: croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose, and povidone. Each inactive peach tablet, for oral administration, in the 28 day regimen contains the following inactive ingredients: anhydrous lactose, FD&C Yellow No. 6 Lake, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Norgestrel is a totally synthetic progestogen, insoluble in water, freely soluble in chloroform, sparingly soluble in alcohol with the chemical name (±)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn- 4-en-20-yn-3-one. Ethinyl estradiol is an estrogen, insoluble in water, soluble in alcohol, in chloroform, in ether, in vegetable oils, and in solutions of fixed alkali hydroxides with the chemical name 19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol. Their structural formulae follow: Therapeutic class: Oral contraceptive. CLINICAL PHARMACOLOGY Combination oral contraceptives act by suppression of gonadotrophins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cer-vical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which may reduce the likelihood of implantation). INDICATIONS AND USAGE Low-Ogestrel (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effe Přečtěte si celý dokument